Northwest Investment Counselors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $193K | Buy |
+184
| New | +$193K | 0.04% | 151 |
|
|
2024
Q2 | – | Sell |
-184
| Closed | -$177K | – | 418 |
|
|
2024
Q1 | $177K | Buy |
+184
| New | +$177K | 0.04% | 147 |
|
|
2023
Q4 | – | Sell |
-188
| Closed | -$155K | – | 441 |
|
|
2023
Q3 | $155K | Hold |
188
| – | – | 0.04% | 157 |
|
|
2023
Q2 | $135K | Buy |
188
+4
| +2% | +$2.87K | 0.04% | 163 |
|
|
2023
Q1 | $151K | Sell |
184
-24
| -12% | -$19.7K | 0.04% | 165 |
|
|
2022
Q4 | $150K | Buy |
208
+194
| +1,386% | +$140K | 0.04% | 169 |
|
|
2022
Q3 | $10K | Hold |
14
| – | – | ﹤0.01% | 365 |
|
|
2022
Q2 | $8K | Hold |
14
| – | – | ﹤0.01% | 391 |
|
|
2022
Q1 | $10K | Hold |
14
| – | – | ﹤0.01% | 390 |
|
|
2021
Q4 | $9K | Buy |
+14
| New | +$9K | ﹤0.01% | 371 |
|
|
2021
Q2 | – | Sell |
-14
| Closed | -$7K | – | 365 |
|
|
2021
Q1 | $7K | Buy |
+14
| New | +$7K | ﹤0.01% | 402 |
|
|
2020
Q4 | – | Sell |
-14
| Closed | -$8K | – | 366 |
|
|
2020
Q3 | $8K | Buy |
+14
| New | +$8K | ﹤0.01% | 349 |
|
|
2019
Q4 | – | Sell |
-14
| Closed | -$4K | – | 417 |
|
|
2019
Q3 | $4K | Buy |
+14
| New | +$4K | ﹤0.01% | 460 |
|